1.Treatment of Rheumatoid Arthritis with Flavonoids in Traditional Chinese Medicine: A Review
Mingjie FAN ; Longfei LIN ; Ruying TANG ; Zhuo XU ; Qian LIAO ; Hui LI ; Yuling LIU
Chinese Journal of Experimental Traditional Medical Formulae 2025;31(17):244-251
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by synovitis as its pathological basis. Although current therapeutic drugs can alleviate symptoms, they are often accompanied by a high risk of side effects. In recent years, the use of flavonoids from traditional Chinese medicine (TCM) in the treatment of RA has garnered significant attention. Studies have shown that the mechanisms by which flavonoids treat RA include inhibiting the release of pro-inflammatory factors, regulating multiple cellular signaling pathways, alleviating oxidative stress, modulating immune system functions, inhibiting bone destruction, and suppressing angiogenesis. Due to their notable anti-inflammatory, antioxidant, and immunomodulatory activities, flavonoids hold promise as potential therapeutic agents for RA. A substantial number of articles in this field have been published. By reviewing Chinese and international literature and applying bibliometric and visual analysis using CiteSpace, this paper explored research hotspots and frontiers in this field, systematically reviewed the structures and anti-RA mechanisms of TCM flavonoids, provided a theoretical basis for their use in RA treatment and clinical applications, and offered new perspectives and references for the discovery of novel TCM-based anti-RA drugs.
2.Treatment of Rheumatoid Arthritis with Flavonoids in Traditional Chinese Medicine: A Review
Mingjie FAN ; Longfei LIN ; Ruying TANG ; Zhuo XU ; Qian LIAO ; Hui LI ; Yuling LIU
Chinese Journal of Experimental Traditional Medical Formulae 2025;31(17):244-251
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by synovitis as its pathological basis. Although current therapeutic drugs can alleviate symptoms, they are often accompanied by a high risk of side effects. In recent years, the use of flavonoids from traditional Chinese medicine (TCM) in the treatment of RA has garnered significant attention. Studies have shown that the mechanisms by which flavonoids treat RA include inhibiting the release of pro-inflammatory factors, regulating multiple cellular signaling pathways, alleviating oxidative stress, modulating immune system functions, inhibiting bone destruction, and suppressing angiogenesis. Due to their notable anti-inflammatory, antioxidant, and immunomodulatory activities, flavonoids hold promise as potential therapeutic agents for RA. A substantial number of articles in this field have been published. By reviewing Chinese and international literature and applying bibliometric and visual analysis using CiteSpace, this paper explored research hotspots and frontiers in this field, systematically reviewed the structures and anti-RA mechanisms of TCM flavonoids, provided a theoretical basis for their use in RA treatment and clinical applications, and offered new perspectives and references for the discovery of novel TCM-based anti-RA drugs.
3.Orexin-A promotes motor function recovery of rats with spinal cord injury by regulating ionotropic glutamate receptors.
Guanglü HE ; Wanyu CHU ; Yan LI ; Xin SHENG ; Hao LUO ; Aiping XU ; Mingjie BIAN ; Huanhuan ZHANG ; Mengya WANG ; Chao ZHENG
Journal of Southern Medical University 2025;45(5):1023-1030
OBJECTIVES:
To investigate the effect of orexin-A-mediated regulation of ionotropic glutamate receptors for promoting motor function recovery in rats with spinal cord injury (SCI).
METHODS:
Thirty-six newborn SD rats (aged 7-14 days) were randomized into 6 groups (n=6), including a normal control group, a sham-operated group, and 4 SCI groups with daily intrathecal injection of saline, DNQX, orexin-A, or orexin-A+DNQX for 3 consecutive days after PCI. Motor function of the rats were evaluated using blood-brain barrier (BBB) score and inclined plane test 1 day before and at 1, 3, and 7 days after SCI. For patch-clamp experiment, spinal cord slices from newborn rats in the control, sham-operated, SCI, and SCI+orexin groups were prepared, and ventral horn neurons were acutely isolated to determine the reversal potential and dynamic indicators of glutamate receptor-mediated currents under glutamate perfusion.
RESULTS:
At 3 and 7 days after SCI, the orexin-A-treated rats showed significantly higher BBB scores and grip tilt angles than those with other interventions. Compared with those treated with DNQX alone, the rats receiving the combined treatment with orexin and DNQX had significantly higher BBB scores and grip tilt angles on day 7 after PCI. In the patch-clamp experiment, the ventral horn neurons from SCI rat models exhibited obviously higher reversal potential and greater rise slope of glutamate current with shorter decay time than those from sham-operated and orexin-treated rats.
CONCLUSIONS
Orexin-A promotes motor function recovery in rats after SCI possibly by improving the function of the ionotropic glutamate receptors.
Animals
;
Spinal Cord Injuries/drug therapy*
;
Rats
;
Rats, Sprague-Dawley
;
Receptors, Ionotropic Glutamate/metabolism*
;
Recovery of Function/drug effects*
;
Orexins/pharmacology*
;
Male
;
Female
;
Animals, Newborn
;
Neuropeptides/pharmacology*
;
Intracellular Signaling Peptides and Proteins/pharmacology*
4.Analysis of risk factors for delay sternal closure after surgery for congenital cardiac disease in children
Yixiao SONG ; Xi CHEN ; Mingjie ZHANG ; Liping WANG ; Yachang PANG ; Zhuoming XU
Chinese Pediatric Emergency Medicine 2024;31(11):851-855
Objective:To prevent postoperative myocardial oedema or other causes of acute heart failure in congenital cardiac disease,anticipating delay sternal closure may reduce the number of children requiring cardiopulmonary resuscitation after surgery.The aim of this study was to describe the rate of delay sternal closure after surgery for congenital cardiac disease and to analyse the risk factors that may be associated with it.Methods:We retrospectively reviewed all surgeries with extracorporeal circulation in the cardiothoracic surgery intensive care unit of Shanghai Children's Medical Center in the past five years,from September 2014 to December 2018.The study cohort was divided into the delay sternal closure group (n=418) and the control group (routine chest closure,n=12 188) according to whether a delay sternal closure was applicated.Risk factors associated with delay sternal closure were identified by multivariate Logistic regression analysis.Results:A total of 12 606 cases were eligible,of which 418 (3.32%) were in the delayed sternal closure group.The most common cardiac diagnosis in the delayed sternal group was transposition of the great arteries (26.8%,112/418),whereas the most common cardiac diagnosis in the control group was ventricular septal defect (45.9%,5 599/12 188).All-cause mortality in children in the delayed sternal closure group was 3.3% (14/418) compared with 0.4% (46/12 188) in the control group,with a statistically significant difference ( P<0.05).Multivariate Logistic regression analysis showed that the need for delayed sternal closure were associated with age ( OR 0.164,95% CI 0.079-0.338, P<0.001),positive intropic support before surgery ( OR 0.42,95% CI 0.252-0.699, P=0.001),sex( OR 0.742,95% CI 0.648-1.098, P<0.05),mean body weight( OR 1.192,95% CI 1.078-1.318, P<0.001),positive intropic support before surgery( OR 0.370,95% CI 0.252-0.699, P<0.001),complicated surgery ( OR 0.241,95% CI 0.159-0.367, P<0.001) and extracorporeal circulation diversion time ( OR 6.412,95% CI 4.339-9.475, P<0.001). Conclusion:Delayed sternal closure is an important management strategy for congenital cardiac surgery in infants and children.Delayed sternal closure is associated with age,sex,mean body weight at the time of surgery,positive intropic support before surgery,complicated surgery and extracorporeal circulation diversion time.
5.Research progress on nursing-sensitive quality indicators for acute poisoning patients
Ying LI ; Jing WEI ; Hua XU ; Ya ZHANG ; Xiangguang YIN ; Mingjie ZHAO ; Jing WANG
Chinese Journal of Modern Nursing 2024;30(30):4191-4196
This article provides a review of domestic and international research on nursing-sensitive quality indicators (NSQIs) and evaluation systems for acute poisoning patients. It organizes the indicators into three dimensions based on the "structure-process-outcome" framework. The need for establishing a unified, comprehensive, and nationally suitable system of NSQIs in China is emphasized to standardize nursing practices and improve the monitoring of care quality. Although existing indicators possess some scientific validity, they often overlap with emergency nursing quality evaluation systems or are limited to specific types of poisoning. In addition, large-scale clinical trials to test their practical application and accessibility have yet to be conducted. This review aims to consolidate and analyze NSQIs for acute poisoning patients and provide a foundation and reference for improving the quality of nursing care for these patients.
6.Mineralization regulation of MAGE-D1 on bone marrowmesenchymal stem cells in knockout mice
Mingjie LU ; Hongyan YUAN ; Dan XU ; Xuelian PENG ; Xuqiang ZOU ; Bo XIE ; Jingwen MAO ; Xiujie WEN
Journal of Army Medical University 2024;46(18):2069-2080
Objective To investigate the effect of melanoma associated antigen D1 (Mage-D1)on mouse femoral bone mass and mineralization ability of mouse bone marrow mesenchymal cells (BMSCs)and its potential molecular mechanism.Methods Female Mage-D1 gene knockout heterozygous mice and male wild-type (WT)mice were subjected as parent mice to breed Mage-D1 gene knockout homozygous (Mage-D1 KO)mice.PCR and agarose gel electrophoresis were used to identify male Mage-D1 knockout (Mage-D1 KO)mice and littermate male wild-type (WT)mice.Micro-CT scanning was performed to observe mouse femoral bone mass,and ELISA and chemical assay were employed to detect serum levels of calcium,phosphorus,calcitonin,and parathyroid hormone in mice.After primary cultured BMSCs were identified with flow cytometry,immunofluorescence staining was utilized to detect the expression of Mage-D1 in BMSCs.BMSCs were infected by Mage-D1 silencing lentivirus,and then the cells were divided into negative control group (sh-NC)and silencing group (sh-Mage-D1).Cell scratch assay was conducted to detect the migration ability of BMSCs,and flow cytometry and CCK-8 assay were conducted to detect the cycle change and proliferation ability of BMSCs.After mineralization induction,alkaline phosphatase (ALP) staining and alizarin red staining were performed;RT-qPCR and Western blotting were used to measure the expression levels of ALP,Runx2 and Col1.RT-qPCR was used to detect mineralization-related genes p75NTR and Msx1.Results Compared with the WT mice,the femoral cortical bone thickness,cortical bone mineral content,cancellous bone mineral content,trabecular number,and cancellous bone surface density were decreased,and trabecular separation was increased in the Mage-D1 knockout homozygous mice (P<0.05).There were no significant changes in the serum levels of calcium,phosphorus,calcitonin and parathyroid hormone in mice after Mage-D1 knockout.Mage-D1 was expressed in the whole BMSCs and was highly expressed in the nucleus and perinuclear regions.Compared with the sh-NC BMSCs,the sh-Mage-D1 group had decreased proliferation ability (P<0.01),enhanced migration ability (P<0.01),and decreased expression of ALP,Runx2 and Col1 genes (P<0.05)and protein (P<0.01)after mineralization induction,milder ALP and alizarin red stain,and lower expression levels of p75NTR and Msx1.Conclusion Mage-D1 knockout can significantly reduce femur bone mass in mice.It can promote the proliferation and inhibit migration of BMSCs,and positively regulate their mineralization in vitro,and the p75NTR-Dlx1/Msx1 signaling axis may be involved in the regulation of bone metabolism by Mage-D1.
7.Clinical observation of tofacitinib combined with hydroxychloroquine in the treatment of refractory rheumatoid arthritis
Mingjie WANG ; Fengjin XU ; Yan ZHANG ; Yan XUE
China Pharmacy 2024;35(6):729-733
OBJECTIVE To observe the clinical efficacy and safety of tofacitinib combined with hydroxychloroquine in the treatment of refractory rheumatoid arthritis (RA). METHODS From January 1, 2021 to January 1, 2022, 120 patients with refractory RA were selected as the study objects. According to the principle of random allocation, the patients were divided into group A, group B and group C, with 40 patients in each group. Group A was given Tofacitinib citrate tablet + Hydroxychloroquine sulfate tablet; group B was given Tofacitinib citrate tablet + Methotrexate tablet; group C was given Tofacitinib citrate tablet + Leflunomide tablet. Three groups were given relevant medicine for 6 months. Therapeutic efficacy and disease activity score 28 (DAS 28) of 3 groups as well as Sharp score, the levels of biochemical indicators [erythrocyte sedimentation rate (ESR), C- reactive protein (CRP)], immune indexes [rheumatoid factor (RF), anti-cyclic peptide containing citrulline (anti-CCP) antibody], serum cytokine indicators [interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α)] before and after treatment were observed; the occurrence of adverse drug reactions during treatment was recorded. RESULTS After treatment, the proportions of ACR50 and ACR70 patients in group A were significantly higher than groups B and C (P<0.05); DAS28 score, Sharp score, biochemical indicators, immune indexes and serum cytokine indicators of 3 groups were significantly lower than before treatment (P<0.05), and gradually decreased with prolonged treatment time; after 6 months of treatment, DAS28 score, Sharp score, RF, anti-CCP antibody, the levels of IL-6 and TNF-α in group A were significantly lower than group B and C (P<0.05). There was no significant difference in the incidence of diarrhea, nausea and vomiting, leukopenia, rash, abnormal liver and kidney function, or dizziness among 3 groups (P>0.05). CONCLUSIONS Tofacitinib combined with hydroxychloroquine shows good efficacy and safety for refractory RA.
8.Effects of marathon exercise on knee cartilage volume and T2 relaxation time
Lingbin XU ; Feng FU ; Xiaofeng YANG ; Qiqian SANG ; Yafei XU ; Mingjie WU ; Lu XUE
Chinese Journal of Orthopaedics 2024;44(5):294-301
Objective:To investigate the effects of marathon exercise on knee cartilage volume and T2 relaxation time (T2 value) based on MRI.Methods:From December 2018 to December 2021, 25 healthy volunteers without long-distance running habits and 32 non-professional marathon runners with long-term long-distance running were recruited to undergo knee MRI 3D water-selective excitation (three dimensional water-selective excitation, 3D-WATS) and T2 mapping imaging were performed, and the cartilage volumes in 5 knee areas and T2 values in 42 subareas were extracted for analysis. To compare the cartilage volume and its ratio to body surface area of knee joint of healthy volunteers and non-professional marathon runners, the T2 value of cartilage in each subregion, and the correlation between marathon exercise intensity and the volume and T2 value of cartilage in different regions.Results:Compared with healthy volunteers, there was no significant difference in cartilage volume or the ratio of body surface area to body volume of non-professional marathon runners ( P>0.05). There were significant differences between healthy volunteers and non-professional marathon runners in cartilage T2 values of the median layer of medial condyle of femur (47.61±5.65 ms and 44.29±6.10 ms) and the deep layer of medial condyle of femur (36.82±9.05 ms and 31.67±7.59 ms), deep precondylar area of medial femur (38.37±4.68 ms and 34.09±4.19 ms), shallow area of medial condylar area of femur (52.17±11.11 ms and 45.51±7.76 ms), middle layer of medial condylar area of femur (49.09±5.08 ms and 45.63±5.04 ms), medial layer of anterior condylar region of lateral femur (45.69±4.68 ms and 42.57±5.77 ms), superficial layer of posterior condylar region of lateral femur (55.42±18.41 ms and 47.99±8.39 ms), deep layer of anterior tibial medial plateau (33.40±7.76 ms and 29.03±5.69 ms), deep layer of posterior tibial medial plateau (31.28±5.02 ms and 27.92±5.99 ms), deep layer of patellofemoral surface (35.65±6.99 ms and 32.30±5.28 ms), respectively ( P<0.05). In non-professional marathon runners, the medial tibial plateau cartilage volume was negatively correlated with step frequency ( r=-0.371, P=0.035), the lateral femoral condylar cartilage volume was negatively correlated with step frequency ( r=-0.365, P=0.043), and the lateral tibial plateau cartilage volume was negatively correlated with step frequency ( r=-0.550, P=0.001). The T2 value of the medial layer cartilage in the anterior tibial medial plateau region was negatively correlated with body weight ( r=-0.277, P=0.039) and body mass index ( r=-0.290, P=0.030). The T2 value of the superficial layer of patellofemoral surface was negatively correlated with the amount of running in 3 months ( r=-0.457, P=0.010). The superficial T2 value in the posterior lateral plateau of the tibia was negatively correlated with stride length ( r=-0.437, P=0.014), and the medial layer cartilage T2 value in the anterior condylar area of the lateral femur was negatively correlated with stride frequency ( r=-0.380, P=0.035). Conclusion:Marathon exercise had little effect on the knee cartilage volume, but had a certain effect on the cartilage T2 value, resulting in changes in cartilage structure. The higher the step frequency, the smaller the cartilage volume. The greater the body weight or body mass index, the greater the amount of running in 3 months, and the greater the stride length, the lower the cartilage T2 value.
9.Clinical efficacy of umbilical moxibustion combined with stone needle acupoint massage for elderly patients with Qi deficiency constipation
Mingjie SHI ; Liangmin WANG ; Kun JI ; Tingting XIANG ; Wei WANG ; Yichen BAI ; Yun YE ; Jing XU ; Bing XU
Chinese Journal of Modern Nursing 2023;29(36):4999-5005
Objective:To explore the clinical efficacy, recurrence rate, and quality of life of elderly patients with Qi deficiency constipation treated with umbilical moxibustion combined with stone needle acupoint massage.Methods:Convenience sampling method was used to select 160 elderly patients with qi deficiency constipation who were hospitalised in the Department of Respiratory Medicine of Dongfang Hospital, Beijing University of Chinese Medicine, Xiyuan Hospital of China Academy of Chinese Medical Sciences, and Guang'anmen Hospital, China Academy of Chinese Medical Sciences from June 2021 to January 2023 as the study subjects. A total of 160 elderly patients with Qi deficiency constipation were randomly divided into four groups by using the method of randomisation of district groups, the control group ( n=40) received routine health education and nursing, the massage group ( n=40) was treated with needle stone acupoint massage, the umbilical moxibustion group ( n=40) received umbilical moxibustion with moxa and ginger, and the massage and umbilical moxibustion group ( n=40) was treated with needle stone acupoint massage combined with umbilical moxibustion. All patients were treated continuously for two weeks. This study compared the clinical efficacy, constipation symptom score, traditional Chinese medicine syndrome score, score of Patient Assessment of Constipation-Quality of Life (PAC-QOL) and the recurrence rate after three months of treatment among four groups of patients. Results:After treatment, compared with the other three groups, the massage and umbilical moxibustion group had the highest total clinical effective rate, with the lowest scores for constipation symptoms, traditional Chinese medicine syndromes, and PAC-QOL, with statistical differences ( P<0.05). There was a statistically significant difference in the recurrence rate among the four groups ( P<0.05) . Conclusions:Needle stone acupoint massage and umbilical moxibustion can both improve the clinical symptoms of elderly patients with Qi deficiency constipation, and combination of the two has a better effect, reducing recurrence rate, and improving quality of life.
10.Erratum: Author correction to "Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles" Acta Pharmaceutica Sinica B 12 (2022) 1523-1533.
Canhao WU ; Qin XU ; Huiyuan WANG ; Bin TU ; Jiaxin ZENG ; Pengfei ZHAO ; Mingjie SHI ; Hong QIU ; Yongzhuo HUANG
Acta Pharmaceutica Sinica B 2023;13(11):4664-4666
[This corrects the article DOI: 10.1016/j.apsb.2021.09.004.].

Result Analysis
Print
Save
E-mail